New York Health Care, Inc. (BBAL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 10, 2025, 8:00 PM EDT
Marinus Pharmaceuticals Revenue
New York Health Care had revenue of $10.59M in the quarter ending September 30, 2008, a decrease of -1.70%. This brings the company's revenue in the last twelve months to $45.78M, up 4.08% year-over-year. In the year 2007, New York Health Care had annual revenue of $44.40M, down -2.00%.
Revenue (ttm)
45.78M
Revenue Growth
+4.08%
P/S Ratio
0.00
Revenue / Employee
31.33K
Employees
1,461
Market Cap
4.36K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 44.40M | -905.30K | -2.00% |
| Dec 31, 2006 | 45.30M | 848.84K | 1.91% |
| Dec 31, 2005 | 44.46M | 2.26M | 5.36% |
| Dec 31, 2004 | 42.20M | 3.68M | 9.54% |
| Dec 31, 2003 | 38.52M | - | - |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |